Get started Log in

XGN — Exagen Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Market Cap
$207.37m
Enterprise Value
$208.33m
Revenue
$66.58m

Exagen Inc expected to post a loss of 56 cents a share - Earnings Preview
13/05/2023 03:02
U.S. RESEARCH ROUNDUP-Adobe, Nike, Roper Technologies
22/03/2023 07:30
Exagen Inc reports results for the quarter ended in December - Earnings Summary
20/03/2023 21:01
Brief: Exagen Inc Reports Q4 Revenue Of $12.8 Million
20/03/2023 20:22
Exagen Inc expected to post a loss of 78 cents a share - Earnings Preview
17/03/2023 20:42
Brief: Exagen Inc Says Company Will Reduce Its Current Workforce By 42 Employees - Filing
05/12/2022 22:23
U.S. RESEARCH ROUNDUP-Caterpillar, Endava, Harpoon Therapeutics
16/11/2022 07:22
Exagen eyes best day in over 2 years on upbeat 2022 sales forecast
15/11/2022 17:16
Exagen Inc reports results for the quarter ended in September - Earnings Summary
14/11/2022 23:26
Brief: Exagen Inc Reports Third Quarter 2022 Results
14/11/2022 21:31
Exagen Inc expected to post a loss of 73 cents a share - Earnings Preview
11/11/2022 21:33
Brief: Exagen Announces Appointment Of John Aballi As CEO
17/10/2022 14:44
Sustainable Switch: China, Brazil and UK to boost solar power
25/08/2022 14:04
Brief: Exagen Initiates Study To Predict Rheumatoid Arthritis Drug Response (Radr) In Patients With Ra
04/08/2022 22:57
Brief: Exagen Inc. Reports Second Quarter 2022 Results
04/08/2022 22:48
Brief: Exagen Releases Largest Comparative Utility Study In Lupus Diagnostics Confirming Avise® Lupus Delivers Unparalleled Utility
05/07/2022 13:28
Brief: Exagen Inc Expands Coverage With Medincrease
09/06/2022 14:46
Exagen Inc reports results for the quarter ended in March - Earnings Summary
12/05/2022 18:04
Brief: Exagen Reports Q1 Revenue Of $10.4 Million
11/05/2022 21:51
Brief: Exagen Inc. Announces New PLA Code And Medicare Pricing For Proprietary Avise Lupus Test
11/05/2022 21:48